Material Agreement, Private Placement (Form 8-K)

Item 1.01 Entry into a Material Definitive Agreement.

On July 29, 2025, Silo Pharma, Inc. (the "Company") entered into an asset purchase agreement (the "Agreement") with MAVS Holdings LLC (the "Seller"). Pursuant to the Agreement, the Seller agreed to sell, and the Company agreed to purchase, certain software of the web-based application currently marketed as "r2crypto.com" and the domain names socialscan.info, coinfeel.net, and r2crypto.com (the "Purchased Assets").

In consideration for the Purchased Assets, the Company issued to the Seller, 750,000 shares of its common stock, par value $0.0001 per share (the "Shares"). The Agreement contains certain representations, warranties and covenants of the parties that are customary for agreements of its type. In addition, the Seller agreed to indemnify the Company for any misrepresentation or breach under the Agreement, infringement of any third-party right by any portion of the software and any acts of gross negligence, fraud or intentional misconduct by the Seller.

The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the Agreement, which will be filed as an exhibit to this Current Report on Form 8-K and incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth under Item 1.01 is incorporated herein by reference.

The offer and sale to the Seller of the Shares was made in reliance upon Section 4(a)(2) under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

Item 8.01 Other Events.

The Company has also acquired the following domain names: (1) silo-crypto.com, (2) silocrypto.com, (3) silocrypto.ai, (4) siloholdingsinc.com, (5) silocryptoholdings.com, and (6) silopharmaventures.com.